Literature DB >> 21745166

Successful T-cell acute lymphoblastic leukemia treatment with proteasome inhibitor bortezomib based on evaluation of nuclear factor-κB activity.

Xiaohui Hu, Jingjing Xu, Aining Sun, Yaying Shen, Guangsheng He, Feng Guo.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21745166     DOI： 10.3109/10428194.2011.593271

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN： 1026-8022


× No keyword cloud information.
  6 in total

1.  Inactivation of ribosomal protein L22 promotes transformation by induction of the stemness factor, Lin28B.

Authors:  Shuyun Rao; Sang-Yun Lee; Alejandro Gutierrez; Jacqueline Perrigoue; Roshan J Thapa; Zhigang Tu; John R Jeffers; Michele Rhodes; Stephen Anderson; Tamas Oravecz; Stephen P Hunger; Roman A Timakhov; Rugang Zhang; Siddharth Balachandran; Gerard P Zambetti; Joseph R Testa; A Thomas Look; David L Wiest
Journal:  Blood       Date:  2012-09-13       Impact factor: 22.113

2.  Bortezomib-containing therapy in Japanese children with relapsed acute lymphoblastic leukemia.

Authors:  Daisuke Hasegawa; Yuri Yoshimoto; Shunsuke Kimura; Tadashi Kumamoto; Naoko Maeda; Junichi Hara; Atsushi Kikuta; Akiko Kada; Toshimi Kimura; Yuka Iijima-Yamashita; Akiko M Saito; Keizo Horibe; Atsushi Manabe; Chitose Ogawa
Journal:  Int J Hematol       Date:  2019-08-10       Impact factor: 2.490

3.  [Bortezomib and obatoclax for dual blockade of protein degradation pathways show synergistic anti-tumor effect in human acute T lymphoblastic leukemia cells].

Authors:  Dan Zhou; Lixia Dai; Xiaolian Liu; Fuchang Que; Yuyan Xu; Xin Luo; Yaolu Zhu; Shuwen Liu; Yilei Li; Le Yu
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2019-04-30

4.  Treatment of refractory/relapsed adult acute lymphoblastic leukemia with bortezomib-based chemotherapy.

Authors:  Junmei Zhao; Chao Wang; Yongping Song; Yuzhang Liu; Baijun Fang
Journal:  Int J Gen Med       Date:  2015-06-12

Review 5.  The Role of Proteasome Inhibitors in Treating Acute Lymphoblastic Leukaemia.

Authors:  Chun-Fung Sin; Pui-Hei Marcus Man
Journal:  Front Oncol       Date:  2021-12-23       Impact factor: 6.244

6.  Treatment of Acute Lymphoid Leukemia Refractory to Classic First-Line and Rescue Protocols.

Authors:  Flávia Tobaldini Russo; Maria Cristina Martins de Almeida Macedo; Pedro Amoedo Fernades; Larissa Yukari Okada; Lucas Augusto Monetta da Silva; Camila Menin Simões; Jamilla Neves Cavalcante; Aline de Almeida Simões; Manuella de Souza Sampaio Almeida; Maricy Almeida Viol Ferreira Lopes; Roberto Luiz da Silva
Journal:  Int J Hematol Oncol Stem Cell Res       Date:  2020-04-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.